SAMH
ALDX icon

Shanda Asset Management Holdings’s Aldeyra Therapeutics ALDX Stock Holding History

Shanda Asset Management Holdings’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31,000
Closed -$129K – 53
2020
Q2 		$129K Buy
+31,000
New +$113K 0.01% 93

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Shanda Asset Management Holdings's ALDX Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Aldeyra Therapeutics (ALDX) in Q3 2020, closing a stake of 31,000 shares — an estimated $129K sold.

Shanda Asset Management Holdings first reported a position in ALDX in Q2 2020 and held it in 1 quarter. The position peaked at $129K in Q2 2020. 87 funds tracked by Wall St. Rank hold ALDX as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Aldeyra Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 31,000 Aldeyra Therapeutics shares in Q3 2020, an estimated $129K.
  • Shanda Asset Management Holdings first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's Aldeyra Therapeutics position peaked at $129K in Q2 2020.
  • 87 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.